An inexpensive and commonly used steroid can save the lives of people seriously ill with COVID-19, a randomized, controlled clinical trial in the United Kingdom has found. The drug, called dexamethasone, is the first shown to reduce deaths from the coronavirus that has killed more than 430,000 people globally. In the trial, it cut deaths by about one-third in patients who were on ventilators because of coronavirus infection.
“It’s a startling result,” says Kenneth Baillie, an intensive-care physician at the University of Edinburgh, UK, who serves on the steering committee of the trial, called RECOVERY. “It will clearly have a massive global impact.”
Dexamethasone is the first drug to show improvement in survival in “Covid-19 patients. This is a very good result
Covid-19 is a mild self-limiting illness that does not require any treatment in the vast majority of cases.
Current evidence based medicine is based on the presumption of significance when P
It can save 1 in 8 severe cases and it's actually supportive. It should be given under medical supervision and we need better option for all COVID-19 cases.
Low dose dexamethasone reduces deaths in hospitalized COVID-19 patients by one third.
https://www.bmj.com/content/bmj/369/bmj.m2422.full.pdf